PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Bismuth→

Bismuth PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
7440-69-9
Molecular formula
Bi
Molecular weight
208.9804 g/mol
Drug class
Inorganic heavy-metal active moietygastrointestinal mucosal protectant and antimicrobial component of bismuth salts
Mechanism of action
Bismuth compounds exert local gastrointestinal effects through mucosal coating and binding to bacterial proteins and toxins. Certain bismuth salts also have antimicrobial activity against Helicobacter pylori and other enteric organisms; the exact mechanism and use depend on the specific salt and formulation.
Indications / reported uses
  • Symptomatic relief of diarrhoea and dyspepsia with authorised bismuth subsalicylate products
  • Component of specific combination regimens for Helicobacter pylori eradication, such as bismuth quadruple therapy; do not assign these indications to all bismuth compounds or formulations

Sources: US DailyMed — Bismuth subsalicylate products · ACG Clinical Guideline — H. pylori treatment · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Bismuth PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Bismuth Permitted Daily Exposure (PDE) report (the Bismuth PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Bismuth Occupational Exposure Limit (OEL) report (the Bismuth OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.